$1.84
Mersana Therapeutics is a biotechnology business based in the US. Mersana Therapeutics shares (MRSN) are listed on the NASDAQ and all prices are listed in US Dollars. Mersana Therapeutics employs 123 staff and has a trailing 12-month revenue of around $38.3 million.
Our top picks for where to buy Mersana Therapeutics stock
- No-cost financial planning and automated investing
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, ETFs and equity options without commission and $0 option contract fees
- Earn up to 8.1% APY on your uninvested cash
- Get a 1.5% match in cash on transferred assets up to $300 or up to 15 free fractional shares worth between $2 and $2,000
How to buy Mersana Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – MRSN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Mersana Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Mersana Therapeutics stock price (NASDAQ: MRSN)
Use our graph to track the performance of MRSN stocks over time.Mersana Therapeutics shares at a glance
Latest market close | $1.84 |
---|---|
52-week range | $0.80 - $6.28 |
50-day moving average | $2.60 |
200-day moving average | $2.72 |
Wall St. target price | $6.57 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.12 |
Is it a good time to buy Mersana Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Mersana Therapeutics price performance over time
Historical closes compared with the close of $1.84 from 2024-07-03
1 week (2024-06-27) | |
---|---|
1 month (2024-06-04) | |
3 months (2024-04-04) | |
6 months (2024-01-04) |
1 year (2023-07-03) | |
---|---|
2 years (2022-07-01) | |
3 years (2021-07-02) | 13.46 |
5 years (2019-07-03) | 4.14 |
Mersana Therapeutics financials
Revenue TTM | $38.3 million |
---|---|
Gross profit TTM | $-146,804,000 |
Return on assets TTM | -33.91% |
Return on equity TTM | -292.19% |
Profit margin | 0% |
Book value | $0.23 |
Market Capitalization | $245.9 million |
TTM: trailing 12 months
Mersana Therapeutics share dividends
We're not expecting Mersana Therapeutics to pay a dividend over the next 12 months.
Mersana Therapeutics share price volatility
Over the last 12 months, Mersana Therapeutics's shares have ranged in value from as little as $0.8014 up to $6.2801. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mersana Therapeutics's is 1.487. This would suggest that Mersana Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Mersana Therapeutics overview
Mersana Therapeutics, Inc. , a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. The company develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen ADC. It has research and development collaborations with Janssen Biotech, Inc. , Ares Trading S. A. , Merck KGaA, and Asana BioSciences, LLC for the development of ADC product candidates.
Frequently asked questions
What percentage of Mersana Therapeutics is owned by insiders or institutions?Currently 1.359% of Mersana Therapeutics shares are held by insiders and 99.478% by institutions. How many people work for Mersana Therapeutics?
Latest data suggests 123 work at Mersana Therapeutics. When does the fiscal year end for Mersana Therapeutics?
Mersana Therapeutics's fiscal year ends in December. Where is Mersana Therapeutics based?
Mersana Therapeutics's address is: 840 Memorial Drive, Cambridge, MA, United States, 02139 What is Mersana Therapeutics's ISIN number?
Mersana Therapeutics's international securities identification number is: US59045L1061 What is Mersana Therapeutics's CUSIP number?
Mersana Therapeutics's Committee on Uniform Securities Identification Procedures number is: 59045L106
More guides on Finder
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
6 best bitcoin ETFs to easily invest in bitcoin through your broker
We analyzed a number of bitcoin ETFs to determine which are best to invest in.
-
11 best trading platforms for beginners [July 2024]
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
6 best ETF brokers for low-cost fund investing [July 2024]
Check out our picks of the best ETF brokers for beginners, options trading, micro-investing and more.
-
5 best international stock brokers to invest in foreign assets
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
-
9 best discount brokers for low-cost trading and investing [July 2024]
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
9 best robo-advisors for affordable, automated portfolio management
Check out our picks of the best robo-advisors for new and experienced investors alike.
-
12 best stock apps of July 2024 to elevate your mobile trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest $50K for growth, passive income and diversification
There are many ways to invest and grow $50K depending on your financial situation, personal needs and goals.
Ask a Question